Monday, August 31, 2020 | Category: Media Coverage
Companies are racing to bolster Covid-19 testing as schools reopen and flu season approaches, saying they aim to avoid a repeat of July when overwhelming demand for testing led to long delays for results.
In a Boston lab where technicians have programmed yeast to produce cannabinoid molecules for medical-marijuana products, scientists are now working to develop a Covid-19 testing system that searches for the virus’s genetic code. The company, Ginkgo Bioworks Inc., hopes by the fall to create a system that will use analyzers the size of washing machines to process 100,000 tests a day.
Meanwhile, scientists at Sonora Quest Laboratories LLC are assembling new equipment that might soon deliver a 10-fold increase in molecular coronavirus-testing capacity at one of Arizona’s largest private labs. Other companies including Abbott Laboratories and public-health authorities are aiming for broader Covid-19 diagnosis and screening with large-scale production of rapid antigen tests that don’t need to be shipped to laboratories for processing.
Read full article